1. Home
  2. XELB vs NRSN Comparison

XELB vs NRSN Comparison

Compare XELB & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xcel Brands Inc.

XELB

Xcel Brands Inc.

BUY

Current Price

$0.36

Market Cap

8.4M

Sector

Miscellaneous

ML Signal

BUY

Logo NeuroSense Therapeutics Ltd.

NRSN

NeuroSense Therapeutics Ltd.

BUY

Current Price

$2.55

Market Cap

7.6M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
XELB
NRSN
Founded
2011
2017
Country
United States
Israel
Employees
N/A
N/A
Industry
Multi-Sector Companies
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.4M
7.6M
IPO Year
2011
2021

Fundamental Metrics

Financial Performance
Metric
XELB
NRSN
Price
$0.36
$2.55
Analyst Decision
Buy
Buy
Analyst Count
2
3
Target Price
$4.00
★ $78.50
AVG Volume (30 Days)
★ 1.4M
17.8K
Earning Date
11-18-2026
09-25-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 48.37
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
$30.13
N/A
Revenue Next Year
$99.55
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.27
$0.25
52 Week High
$2.47
$7.50

Technical Indicators

Market Signals
Indicator
XELB
NRSN
Relative Strength Index (RSI) 26.27 37.25
Support Level $0.27 $0.63
Resistance Level $1.16 $7.50
Average True Range (ATR) 0.09 0.37
MACD -0.00 -0.24
Stochastic Oscillator 15.71 14.04

Price Performance

Historical Comparison
XELB
NRSN

About XELB Xcel Brands Inc.

Xcel Brands Inc is a media and brand management company. It is engaged in design, merchandising and planning, sourcing and production, licensing, marketing, and brand development. The company offers branded apparel, footwear, accessories, jewelry, home goods, and other consumer products. Its brand portfolio consists of the Isaac Mizrahi, Judith Ripka, H Halston, C Wonder, and the Highline Collective brands. The company licenses its brands to third parties, provides certain designs, production, and marketing services, and generates licensing, design, and service fee revenues through contractual arrangements and other agreements.

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

Share on Social Networks: